NO992846D0 - Leukotrine antagonists for oral squamous cell cancer - Google Patents
Leukotrine antagonists for oral squamous cell cancerInfo
- Publication number
- NO992846D0 NO992846D0 NO992846A NO992846A NO992846D0 NO 992846 D0 NO992846 D0 NO 992846D0 NO 992846 A NO992846 A NO 992846A NO 992846 A NO992846 A NO 992846A NO 992846 D0 NO992846 D0 NO 992846D0
- Authority
- NO
- Norway
- Prior art keywords
- squamous cell
- cell cancer
- oral squamous
- leukotrine
- antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3426996P | 1996-12-13 | 1996-12-13 | |
| US4087497P | 1997-03-21 | 1997-03-21 | |
| PCT/US1997/021953 WO1998025615A1 (en) | 1996-12-13 | 1997-12-02 | Leukotriene antagonists for oral squamous cell carcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO992846D0 true NO992846D0 (en) | 1999-06-11 |
| NO992846L NO992846L (en) | 1999-06-11 |
Family
ID=26710754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO992846A NO992846L (en) | 1996-12-13 | 1999-06-11 | Leukotrine antagonists for oral squamous cell cancer |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0964683A4 (en) |
| JP (1) | JP2001509142A (en) |
| KR (1) | KR20000069452A (en) |
| CN (1) | CN1245429A (en) |
| AU (1) | AU726215B2 (en) |
| CA (1) | CA2274855A1 (en) |
| EA (1) | EA002742B1 (en) |
| IL (1) | IL130304A0 (en) |
| NO (1) | NO992846L (en) |
| NZ (1) | NZ335922A (en) |
| PL (1) | PL334241A1 (en) |
| TR (1) | TR199901307T2 (en) |
| UA (1) | UA47505C2 (en) |
| WO (1) | WO1998025615A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004505047A (en) | 2000-07-28 | 2004-02-19 | キャンサー・リサーチ・テクノロジー・リミテッド | Cancer treatment by combined therapy |
| GB0121285D0 (en) | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| GB2386836B (en) | 2002-03-22 | 2006-07-26 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| GB2394658A (en) | 2002-11-01 | 2004-05-05 | Cancer Rec Tech Ltd | Oral anti-cancer composition |
| US8093253B2 (en) * | 2008-03-06 | 2012-01-10 | Hoffmann-La Roche Inc. | Leukotriene B4 inhibitors |
| KR101898879B1 (en) | 2014-03-05 | 2018-09-14 | 재단법인 진안홍삼연구소 | A composition comprising the red ginseng extract of postmanufacture for treating or preventing oral squamous cell carcinoma |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6372648A (en) * | 1986-09-16 | 1988-04-02 | Sumitomo Pharmaceut Co Ltd | Novel unsaturated fatty acid derivative |
| PH30449A (en) * | 1991-11-25 | 1997-05-28 | Lilly Co Eli | Substituted phenyl phenol leukotriene antagonists |
| DK0544488T3 (en) * | 1991-11-25 | 1998-04-06 | Lilly Co Eli | Substituted phenylphenol leukotriene antagonists |
-
1997
- 1997-02-12 UA UA99063226A patent/UA47505C2/en unknown
- 1997-12-02 IL IL13030497A patent/IL130304A0/en unknown
- 1997-12-02 JP JP52676298A patent/JP2001509142A/en not_active Ceased
- 1997-12-02 WO PCT/US1997/021953 patent/WO1998025615A1/en not_active Application Discontinuation
- 1997-12-02 AU AU78451/98A patent/AU726215B2/en not_active Ceased
- 1997-12-02 EA EA199900543A patent/EA002742B1/en not_active IP Right Cessation
- 1997-12-02 CA CA002274855A patent/CA2274855A1/en not_active Abandoned
- 1997-12-02 PL PL97334241A patent/PL334241A1/en unknown
- 1997-12-02 KR KR1019997005275A patent/KR20000069452A/en not_active Application Discontinuation
- 1997-12-02 NZ NZ335922A patent/NZ335922A/en unknown
- 1997-12-02 EP EP97949709A patent/EP0964683A4/en not_active Withdrawn
- 1997-12-02 TR TR1999/01307T patent/TR199901307T2/en unknown
- 1997-12-02 CN CN97181730A patent/CN1245429A/en active Pending
-
1999
- 1999-06-11 NO NO992846A patent/NO992846L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001509142A (en) | 2001-07-10 |
| EA199900543A1 (en) | 2000-02-28 |
| UA47505C2 (en) | 2002-07-15 |
| TR199901307T2 (en) | 1999-08-23 |
| CA2274855A1 (en) | 1998-06-18 |
| IL130304A0 (en) | 2000-06-01 |
| NO992846L (en) | 1999-06-11 |
| CN1245429A (en) | 2000-02-23 |
| AU726215B2 (en) | 2000-11-02 |
| EP0964683A4 (en) | 2002-08-14 |
| EA002742B1 (en) | 2002-08-29 |
| EP0964683A1 (en) | 1999-12-22 |
| NZ335922A (en) | 2000-12-22 |
| PL334241A1 (en) | 2000-02-14 |
| WO1998025615A1 (en) | 1998-06-18 |
| KR20000069452A (en) | 2000-11-25 |
| AU7845198A (en) | 1998-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69835280D1 (en) | HEALTHY CIGARETTE | |
| IT1298518B1 (en) | REAMER | |
| DE59711759D1 (en) | Rate-adaptive pacemaker | |
| DE69707107D1 (en) | RHEOLOGICALLY MODIFIED POLYOLEFINS | |
| DE69730043T8 (en) | IMPLANTABLE ELECTRODE LINE | |
| DE69626136D1 (en) | TOOTHBRUSH | |
| DE69707441D1 (en) | TOOTHBRUSH | |
| DE69720061D1 (en) | TOOTHBRUSH | |
| DE69735595D1 (en) | TOOTHBRUSH | |
| DK0873066T3 (en) | Toothbrush | |
| DE59909242D1 (en) | REFERENCE ELECTRODE | |
| DE69702130D1 (en) | TOOTHBRUSH | |
| BR9705756A (en) | Dental reamer | |
| ATE493907T1 (en) | TOOTHBRUSH | |
| NO971755L (en) | Feed for smolt | |
| DK1135381T3 (en) | eletriptan | |
| DE69740017D1 (en) | TOOTHBRUSH | |
| DE69725330D1 (en) | PACEMAKER | |
| DE69723404D1 (en) | electrode | |
| NO992846L (en) | Leukotrine antagonists for oral squamous cell cancer | |
| DE69826579D1 (en) | Milling device with elliptical milling cutters | |
| DE69721502D1 (en) | cutter body | |
| DE69634991D1 (en) | ELECTROTHERAPY UNIT | |
| DE59705673D1 (en) | TOOTHBRUSH | |
| LV12081A (en) | High-energy batteries |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |